# A Study of Direct Oral Anticoagulants in Patients with Painful Venous Malformations with Localized Intravascular Coagulation

> **NCT06729034** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Oslo University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Venous Malformation, Low Flow
- Anticoagulants

## Interventions

- **DRUG:** Apixaban (Eliquis)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06729034
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2030-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06729034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06729034, "A Study of Direct Oral Anticoagulants in Patients with Painful Venous Malformations with Localized Intravascular Coagulation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06729034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*